Diego Orsini

722 total citations
33 papers, 241 citations indexed

About

Diego Orsini is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Diego Orsini has authored 33 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Dermatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Diego Orsini's work include Psoriasis: Treatment and Pathogenesis (15 papers), Dermatology and Skin Diseases (7 papers) and Autoimmune Bullous Skin Diseases (5 papers). Diego Orsini is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (15 papers), Dermatology and Skin Diseases (7 papers) and Autoimmune Bullous Skin Diseases (5 papers). Diego Orsini collaborates with scholars based in Italy, United States and France. Diego Orsini's co-authors include Alessandra Narcisi, Antonio Costanzo, Antonio Cristaudo, Alessandra Latini, Marco Innamorati, Alberto Forte, Dorian A. Lamis, Denise Erbuto, Elisabetta Botti and Paolo Girardi and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Health Services Research and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Diego Orsini

30 papers receiving 232 citations

Peers

Diego Orsini

IMMUN

DERMA

RHEUM

PMH

PFM

Marwa Hakimi United States

Muriel Sadlier Ireland

Nihal Kundakçı Türkiye

F. Maccari France

Giulia Calabrese Italy

Ayşe Esra Koku Aksu Türkiye

MW Lin Taiwan

Ayman Abdelmaksoud Egypt

Megan A. Kinney United States

Bengü Çevirgen Cemil Türkiye

Marwa Hakimi United States

Diego Orsini

127 ×1.1

IMMUN

84 ×0.8

DERMA

31 ×0.7

RHEUM

9 ×0.3

PMH

29 ×0.9

PFM

Citations per year, relative to Diego Orsini Diego Orsini (= 1×) peers Marwa Hakimi

Countries citing papers authored by Diego Orsini

Since Specialization

Citations

This map shows the geographic impact of Diego Orsini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Orsini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Orsini more than expected).

Fields of papers citing papers by Diego Orsini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Orsini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Orsini. The network helps show where Diego Orsini may publish in the future.

Co-authorship network of co-authors of Diego Orsini

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Orsini. A scholar is included among the top collaborators of Diego Orsini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Orsini. Diego Orsini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Arino, Andrea, Maria Concetta Fargnoli, Pasquale Frascione, et al.. (2025). Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series. Dermatology Reports.

Lanna, Caterina, Gaetana Costanza, Diego Orsini, et al.. (2025). Tildrakizumab as a Potential Option for Early Psoriatic Arthritis in Patients with Metabolic Comorbidities and Psoriasis: a Case Series. Dermatology Practical & Conceptual. 15(4). 5570–5570.

Bernardini, Nicoletta, Annunziata Dattola, Giacomo Caldarola, et al.. (2024). Rapid response on facial psoriasis to bimekizumab: case series. Drugs in Context. 13. 1–6. 2 indexed citations

Valenti, Mario, Luigi Gargiulo, Luciano Ibba, et al.. (2024). Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study. The Journal of Dermatology. 51(6). 839–843. 5 indexed citations

Zangrilli, Arianna, Giacomo Caldarola, Viviana Lora, et al.. (2024). Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real‐world study. International Journal of Dermatology. 63(10). 1383–1391. 1 indexed citations

Orsini, Diego, Andrea D’Arino, Paolo Iacovelli, et al.. (2023). SARS-CoV-2: an environmental trigger of Darier’s disease?. Journal of Dermatological Treatment. 34(1). 2242541–2242541. 1 indexed citations

Orsini, Diego, Luciano Ibba, Alessandra Narcisi, et al.. (2023). Long-term management of pediatric psoriasis with ixekizumab: a case report. Journal of Dermatological Treatment. 34(1). 2198622–2198622. 2 indexed citations

Orsini, Diego, et al.. (2023). Rapidly and successful improvement of nail psoriasis with risankizumab. SHILAP Revista de lepidopterología. 11(10). e8035–e8035. 2 indexed citations

Strumia, Silvia, et al.. (2023). Stroke pathway performance assessment: a retrospective observational study. BMC Health Services Research. 23(1). 1391–1391. 1 indexed citations

10.

Orsini, Diego, Luigi Gargiulo, Luciano Ibba, et al.. (2023). Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers. Journal of Dermatological Treatment. 34(1). 2220849–2220849. 10 indexed citations

11.

Narcisi, Alessandra, Nicoletta Bernardini, Diego Orsini, et al.. (2020). Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study). Advances in Dermatology and Allergology. 37(3). 428–434. 13 indexed citations

12.

Latini, Alessandra, Maria Gabriella Donà, Manuela Colafigli, et al.. (2019). Recreational drugs and STI diagnoses among patients attending an STI/HIV reference clinic in Rome, Italy. Sexually Transmitted Infections. 95(8). 588–593. 13 indexed citations

13.

Orsini, Diego, et al.. (2018). Allergic contact dermatitis to dorzolamide and benzalkonium chloride. Advances in Dermatology and Allergology. 35(5). 538–539. 6 indexed citations

14.

Latini, Alessandra, Carlo Cota, Diego Orsini, Antonio Cristaudo, & M Tedesco. (2018). Male and female genital lichen sclerosus. Clinical and functional classification criteria. Advances in Dermatology and Allergology. 35(5). 447–453. 17 indexed citations

15.

Pompili, Maurizio, Marco Innamorati, Alessandra Narcisi, et al.. (2016). Suicide risk and psychiatric comorbidity in patients with psoriasis. Journal of International Medical Research. 44(1_suppl). 61–66. 52 indexed citations

16.

Carlesimo, Marta, Alessandra Narcisi, Alfredo Rossi, et al.. (2013). Cutaneous manifestations of systemic non‐Hodgkin lymphomas (NHL): study and review of literature. Journal of the European Academy of Dermatology and Venereology. 28(2). 133–141. 8 indexed citations

17.

Carlesimo, Marta, et al.. (2012). A Case of Cutaneous Large B-Cell Lymphoma of the Legs Appearing as Chronic Venous Ulceration. SHILAP Revista de lepidopterología. 4(2). e6–e6. 2 indexed citations

18.

Carlesimo, Marta, et al.. (2012). Nodular melanoma arising in a patient treated with anti‐tumor necrosis factor alpha antagonists. International Journal of Dermatology. 51(10). 1234–1236. 3 indexed citations

19.

Carlesimo, Marta, et al.. (2011). A case of lichen amyloidosus treated with acitretin.. PubMed. 162(2). e59–61. 12 indexed citations

20.

Proietti, Ilaria, Nevena Skroza, Nicoletta Bernardini, et al.. (2011). Acitretin in management of diffuse common warts: a case report. Dermatologic Therapy. 24(6). 581–583. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact